Lupin logo

LUPIN - Lupin News Story

₹1212.25 14.9  1.2%

Last Trade - 12/05/21

Large Cap
Market Cap £5.30bn
Enterprise Value £5.50bn
Revenue £1.47bn
Position in Universe 81st / 3110

BRIEF-Lupin says gets US FDA nod for generic versions of Monodox and Cipro

Thu 6th March, 2014 9:42am
March 6 (Reuters) - Lupin Ltd  LUPN.NS : * Says gets US FDA approval for its Doxycycline capsules * Says also received final approval from the FDA for its Ciprofloxacin for oral suspension * Further company coverage  LUPN.NS  ((Bangalore Newsroom; +91 80 6749 1130))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.